Literature Collection

4241

Gaps In Access To Opioid Use Disorder Treatment For Medicare Beneficiaries

Type: Journal Article

Authors: Samantha J. Harris, Amanda J. Abraham, Christina M. Andrews, Courtney R. Yarbrough

Year: 2020

Publication Place: Chevy Chase

Topic(s):

, ,

Reference Links:

Export Citation: RIS

View details

4242

Gaps in Research and Care for Adults with a Disability Who Have Substance Use Disorders: Treatment

Type: Government Report

Authors: Victoria Lynch, Lisa Clemans-Cope

Year: 2024

Publication Place: Washington, D.C.

Topic(s):

, ,

Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

PDF (562.2 KB)

Reference Links: PDF (562.2 KB)

Export Citation: RIS

View details

4243

Garnering partnerships to bridge gaps among mental health, health care, and public health

Type: Journal Article

Authors: E. Freeman, L. Presley-Cantrell, V. J. Edwards, S. White-Cooper, K. S. Thompson, S. Sturgis, J. B. Croft

Year: 2010

Publication Place: United States

Abstract: Integrating mental health and public health chronic disease programs requires partnerships at all government levels. Four examples illustrate this approach: 1) a federal partnership to implement mental health and mental illness modules in the Behavioral Risk Factor Surveillance System; 2) a state partnership to improve diabetes health outcomes for people with mental illness; 3) a community-level example of a partnership with local aging and disability agencies to modify a home health service to reduce depression and improve quality of life among isolated, chronically ill seniors; and 4) a second community-level example of a partnership to promote depression screening and management and secure coverage in primary care settings. Integration of mental health and chronic disease public health programs is a challenging but essential and achievable task in protecting Americans' health.

Topic(s):

Reference Links:

Export Citation: RIS

View details

4244

Gender and age effects on the trajectory of depression in opioid users during methadone maintenance treatment

Type: Journal Article

Authors: Peng-Wei Wang, Huang-Chi Lin, Yi-Hsin Connie Yang, Chih-Yao Hsu, Kuan-Sheng Chung, Hung-Chi Wu, Cheng-Fang Yen

Year: 2017

Topic(s):

,

Reference Links:

Export Citation: RIS

View details

4245

Gender and symptoms in primary care practices

Type: Journal Article

Authors: J. L. Jackson, J. Chamberlin, K. Kroenke

Year: 2003

Publication Place: United States

Abstract: The authors sought to explore gender differences among patients with physical symptoms who came to see internists. The women were younger, more likely to report stress, endorsed more "other, currently bothersome" symptoms, were more likely to have a mental disorder, and were less likely to be satisfied with their care. The men were slower to improve, but there was no difference between the sexes after 3 months. There were no differences in the number, type, duration, or severity of symptoms or in the expectation of care, costs of visits, intervention received, use of health care services, or likelihood of being considered difficult by their physician. The gender of the clinician had no effect on any outcome.

Topic(s):

,

Reference Links:

Export Citation: RIS

View details

4246

Gender Differences among Prisoners with Pre-Incarceration Heroin Dependence Participating in a Randomized Clinical Trial of Buprenorphine Treatment

Type: Journal Article

Authors: Michael S. Gordon, Timothy W. Kinlock, Kathryn A. Couvillion, Monique E. Wilson, Robert P. Schwartz, Kevin E. O'Grady

Year: 2013

Topic(s):

,

Export Citation: RIS

View details

4247

Gender differences in adolescents attending a drug and alcohol withdrawal service

Type: Journal Article

Authors: A. J. Dean, M. McBride, E. M. Macdonald, Y. Connolly, B. M. McDermott

Year: 2010

Publication Place: England

Abstract: INTRODUCTION AND AIMS: Gender differences have been reported in adult substance users, but little research has examined gender differences in adolescents presenting to treatment services. This study aimed to explore gender differences in adolescents presenting to a withdrawal service. DESIGN AND METHODS: All presentations to a withdrawal service between March 2000 and September 2004 were identified. For each presentation, the following information was extracted from clinical databases: sociodemographics, drug use, risk-taking behaviour, mental health symptoms, reasons and context of drug use. Significant gender differences identified at bivariate analysis were then incorporated into multivariate models exploring predictors of heroin use, cannabis use and sharing injecting equipment. RESULTS: A total of 262 young people were admitted during the study period (53% male, mean age 16.8 years; SD 1.13). Bivariate analysis indicated that girls were more likely to report: being homeless, using a greater number of substances, using heroin and amphetamines, higher rates of injecting, sharing injecting equipment and using with a partner. Multivariate analysis identified that being female was an independent predictor of heroin use and that being male was an independent predictor of cannabis use. Significant predictors of sharing injecting equipment were using with a partner and current use of heroin; the effect of gender was not significant after controlling for other factors. DISCUSSION AND CONCLUSIONS: Our findings indicate that male and female adolescents presenting to a withdrawal treatment service exhibit differences in substance use characteristics. Future research should examine the role of gender in determining optimal treatment approaches in substance-using adolescents.

Topic(s):

,

Reference Links:

Export Citation: RIS

View details

4248

Gender differences in demographic and clinical characteristics of patients with opioid use disorder entering a comparative effectiveness medication trial

Type: Journal Article

Authors: A. N. C. Campbell, C. Barbosa-Leiker, M. Hatch-Maillette, S. E. Mennenga, M. Pavlicova, J. Scodes, T. Saraiya, S. G. Mitchell, J. Rotrosen, P. Novo, E. V. Nunes, S. F. Greenfield

Year: 2018

Publication Place: England

Topic(s):

,

Reference Links:

Export Citation: RIS

View details

4249

Gender differences in drug use among individuals under arrest

Type: Journal Article

Authors: Bridget E. Weller, Stephen Magura, Dawn R. Smith, Matthew M. Saxton, Piyadarsha Amaratunga

Year: 2022

Topic(s):

,

Reference Links:

Export Citation: RIS

View details

4250

Gender differences in health-related quality of life on admission to a maintenance treatment program

Type: Journal Article

Authors: S. M. Giacomuzzi, Y. Riemer, M. Ertl, G. Kemmler, H. Rossler, H. Hinterhuber, M. Kurz

Year: 2005

Publication Place: Switzerland

Topic(s):

Reference Links:

Export Citation: RIS

View details

4251

Gender differences in mortality among treated opioid dependent patients

Type: Journal Article

Authors: E. Evans, A. Kelleghan, L. Li, J. Min, D. Huang, D. Urada, Y. I. Hser, B. Nosyk

Year: 2015

Publication Place: Ireland

Abstract: AIMS: To assess gender differences in characteristics, mortality rates, and the causes and predictors of death among treated opioid-dependent individuals. METHODS: Linked vital statistics data were obtained for all individuals first enrolled in publicly funded pharmacological treatment for opioid dependence in California from 2006 to 2010. Standardized mortality ratios (SMR) were calculated by gender. Cox proportional hazards models with time-varying covariates were fitted to determine the effect of gender on the hazard of all-cause mortality, controlling for covariates. RESULTS: Over a median 2.6 years (interquartile range: 1.4-3.7), 1.031 deaths were observed, including 2.2% (259/11,564) of women and 3.7% (772/20,758) of men. Women had a greater increased risk of mortality compared to the general population (SMR 5.1 95% CI: 4.5, 5.7) than men (SMR 4.3 95% CI: 4.0, 4.6). The relative risk of death for women compared with men was 1.18 (95% CI: 1.02, 1.36). Women had a lower instantaneous hazard of all-cause mortality than men (HR 0.58, 95% CI 0.50, 0.68), controlling for other factors. Significant interaction effects indicated that among men, mortality risk was decreased by full-time employment and increased by non-daily heroin use (relative to daily use) and medical problems. Concurrent opioid and methamphetamine/cocaine use increased mortality risk among women and decreased it among men. CONCLUSIONS: Treatment for opioid dependence is likely to reduce mortality risk among men by addressing employment and medical problems, and via interventions to reduce overdose risk after heroin abstinence, and among women by attending to the concurrent use of methamphetamine/cocaine and opioids.

Topic(s):

Reference Links:

Export Citation: RIS

View details

4252

Gender Differences in Prevalence of Somatoform Disorders in Patients Visiting Primary Care Centers: Original Research

Type: Journal Article

Authors: Abdulbari Bener

Year: 2010

Publication Place: United States

Topic(s):

,

Reference Links:

Export Citation: RIS

View details

4253

Gender differences in receipt of telehealth versus in person behavioral therapy, medication for opioid use disorder (MOUD), and 90-day MOUD retention during the pandemic: A retrospective veteran cohort study

Type: Journal Article

Authors: N. A. Livingston, A. Sarpong, R. Sistad, C. Roth, A. N. Banducci, T. Simpson, J. Hyde, M. Davenport, R. Weisberg

Year: 2024

Abstract:

BACKGROUND: COVID-19 significantly negatively impacted access to care among patients with opioid use disorder (OUD). The Veterans Health Administration (VHA) enacted policies to expand telehealth and medication for OUD (MOUD) during the public health emergency, which offset risk of treatment disruption. In this study, we evaluated gender differences in utilization of behavioral therapy in person and via telehealth, MOUD utilization, and achieving 90-day MOUD retention pre-post pandemic onset, given known gender differences in treatment utilization between men and women. Secondarily, we examined MOUD receipt and retention as a function of in-person vs. telehealth behavioral therapy received over time. METHODS: Using VHA's nationwide electronic health record data, we compared outcomes between men and women veterans, pre- to post-pandemic onset (January 2019-February 2020 vs. March 2020-April 2021). Primary outcomes included receipt of behavioral therapy (in person or telehealth), number of appointments attended, any MOUD, and whether patients achieved 90-day MOUD retention post-induction. RESULTS: Veterans with OUD were less likely to receive behavioral therapy post-pandemic onset, which was driven by marked decreases in in-person care; these effects were strongest among women. The odds of receiving MOUD also decreased pre- to post-pandemic onset, particularly among men. Receipt of or achieving 90-day MOUD retention was differentially related to receipt of behavioral therapy via in person vs. telehealth; telehealth was more strongly associated with these utilization indicators post-pandemic onset-an effect that was more pronounced for men. CONCLUSION: The likelihood of receiving behavioral therapy and MOUD were lower during COVID-19 and varied by gender, with men being less likely to receive MOUD over time and women being less likely to receive in-person behavioral therapy. Behavioral therapy received via telehealth was generally associated with improved MOUD utilization compared to in-person behavioral therapy, but this was less true for women than for men regarding utilization of or achieving 90-day MOUD retention. In addition to the need for further telehealth expansion for veterans with OUD, more research should explore how to better engage men in MOUD treatment and improve adherence to MOUD among women engaged in behavioral therapy.

Topic(s):

, ,

Reference Links:

Export Citation: RIS

View details

4254

Gender differences in the stress-buffering effects of mindfulness facets on substance use among low-income adolescents

Type: Journal Article

Authors: E. C. Helminen, T. L. Ash, E. L. Cary, S. E. Sinegar, P. Janack, R. DiFlorio, J. C. Felver

Year: 2023

Topic(s):

,

Reference Links:

Export Citation: RIS

View details

4255

Gender differences in treatment and clinical characteristics among patients receiving extended release naltrexone

Type: Journal Article

Authors: D. M. Herbeck, K. E. Jeter, S. J. Cousins, R. Abdelmaksoud, D. Crevecoeur-MacPhail

Year: 2016

Abstract: Further research is needed to investigate real-world acceptability of extended-release naltrexone for alcohol and opioid use disorders, and potential gender differences. This study examines treatment and clinical characteristics among men and women receiving extended-release naltrexone in a large, publicly funded substance use disorder treatment system (N = 465; 52% female). Patient demographics, treatment characteristics, and the number of extended-release naltrexone doses received were collected from administrative data and treatment program staff. Additionally, patients provided information on experiences with extended-release naltrexone in an open-ended format at 1, 2, and 3 weeks following their first injection. For a subsample of patients (N = 220), alcohol/opioid cravings and specific adverse effects were also assessed. Compared to men, women reported experiencing a higher rate and mean number of adverse effects. Overall, craving scores showed substantial reductions over time. However, among patients taking extended-release naltrexone for alcohol use, women showed a significantly greater reduction in craving scores compared to men. No gender differences were observed in the number of extended-release naltrexone doses received. Although women may have a greater need for additional support in managing early adverse effects, extended-release naltrexone as an adjunct to psychosocial treatment may be an acceptable and promising treatment approach for both men and women, and particularly for women prescribed extended-release naltrexone for alcohol use. This study contributes further information on patients' experiences during the early course of extended-release naltrexone treatment in real-world settings. Understanding these experiences may assist policy makers and treatment providers in addressing challenges of implementing this treatment into wider practice.

Topic(s):

Reference Links:

Export Citation: RIS

View details

4256

Gender differences of mental health consumers accessing integrated primary and behavioral care

Type: Journal Article

Authors: H. Gleason, M. Hobart, L. Bradley, J. Landers, S. Langenfeld, M. Tonelli, M. Kolodziej

Year: 2014

Abstract: Persons with severe mental illness and addiction are at higher risk for early morbidity and mortality than the general population, and are less likely to receive primary care and preventive health services. Primary and behavioral integrated care programs aim to reduce these health disparities by providing comprehensive health and wellness services. Gender in particular may play a significant role in individuals' engagement and outcomes in such programs. Hence, this study examines the salient characteristics of behavioral health consumers accessing an integrated care program at a large community mental health center. Baseline gender differences in consumer demographics, substance use, psychological distress and functioning, physical health indicators, and risk factors for serious medical conditions are examined. Our results demonstrate that key gender differences exist and may warrant distinct treatment needs for men and women receiving integrated care.

Topic(s):

Reference Links:

Export Citation: RIS

View details

4257

Gender disparities in physician-patient communication among African American patients in primary care

Type: Journal Article

Authors: Robin Dimatteo, Carolyn B. Murray, Summer L. Williams

Year: 2009

Publication Place: United States

Topic(s):

,

Reference Links:

Export Citation: RIS

View details

4258

Gender disparities in the treatment of late-life depression: qualitative and quantitative findings from the IMPACT trial

Type: Journal Article

Authors: L. Hinton, M. Zweifach, S. Oishi, L. Tang, J. Unutzer

Year: 2006

Topic(s):

Export Citation: RIS

View details

4259

Gender Issues in the Pharmacotherapy of Opioid-Addicted Women: Buprenorphine

Type: Journal Article

Authors: Annemarie Unger, Erika Jung, Bernadette Winklbaur, Gabriele Fischer

Year: 2010

Topic(s):

,

Export Citation: RIS

View details

4260

Gender-related self-reported mental health inequalities in primary care in England: a cross-sectional analysis using the GP Patient Survey

Type: Journal Article

Authors: R. E. Watkinson, A. Linfield, J. Tielemans, I. Francetic, L. Munford

Year: 2024

Topic(s):

,

Reference Links:

Export Citation: RIS

View details